Search Results - "Dempsey, Timothy M."

Refine Results
  1. 1

    Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis by Dempsey, Timothy M, Sangaralingham, Lindsey R, Yao, Xiaoxi, Sanghavi, Darshak, Shah, Nilay D, Limper, Andrew H

    “…Since their approval, there has been no real-world or randomized trial evidence evaluating the effect of the antifibrotic medications pirfenidone and…”
    Get full text
    Journal Article
  2. 2

    Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis by Teague, Taylor T, Payne, Stephanie R, Kelly, Bryan T, Dempsey, Timothy M, McCoy, Rozalina G, Sangaralingham, Lindsey R, Limper, Andrew H

    Published in Respiratory research (11-04-2022)
    “…Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with high morbidity and limited treatment options. Type 2 diabetes mellitus (T2DM) is…”
    Get full text
    Journal Article
  3. 3

    Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States by Dempsey, Timothy M, Thao, Viengneesee, Moriarty, James P, Borah, Bijan J, Limper, Andrew H

    Published in BMC pulmonary medicine (10-01-2022)
    “…The anti-fibrotic medications nintedanib and pirfenidone were approved in the United States for use in patients with idiopathic pulmonary fibrosis several…”
    Get full text
    Journal Article
  4. 4

    Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment by Herberts, Michelle B, Teague, Taylor T, Thao, Viengneesee, Sangaralingham, Lindsey R, Henk, Henry J, Hovde, Kevin T, Dempsey, Timothy M, Limper, Andrew H

    Published in BMC pulmonary medicine (02-08-2023)
    “…Create a timeline of diagnosis and treatment for IPF in the US. A retrospective analysis was performed in collaboration with the OptumLabs Data Warehouse using…”
    Get full text
    Journal Article
  5. 5

    Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study by Jeffery, Molly Moore, Oliveira J e Silva, Lucas, Bellolio, Fernanda, Garovic, Vesna D, Dempsey, Timothy M, Limper, Andrew, Cummins, Nathan W

    Published in BMJ open (01-07-2022)
    “…ObjectivesEvaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute…”
    Get full text
    Journal Article
  6. 6

    Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort study by Jeffery, Molly Moore, Cummins, Nathan W, Dempsey, Timothy M, Limper, Andrew H., Shah, Nilay D, Bellolio, Fernanda

    Published in BMJ open (17-03-2021)
    “…ObjectivesEvaluate associations between ACE inhibitors (ACEis) and angiotensin receptor blockers (ARBs) and clinical outcomes in acute viral respiratory…”
    Get full text
    Journal Article
  7. 7

    Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications by Kelly, Bryan T, Thao, Viengneesee, Dempsey, Timothy M, Sangaralingham, Lindsey R, Payne, Stephanie R, Teague, Taylor T, Moua, Teng, Shah, Nilay D, Limper, Andrew H

    Published in BMC pulmonary medicine (17-07-2021)
    “…Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pulmonary Function Tests for the Generalist: A Brief Review by Dempsey, Timothy M., Scanlon, Paul D.

    Published in Mayo Clinic proceedings (01-06-2018)
    “…One of the frequent reasons patients see their primary care physicians is for the symptom of dyspnea. Among the objective tests to quantify this symptom is the…”
    Get full text
    Journal Article
  10. 10

    The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Design in Idiopathic Pulmonary Fibrosis Research by Dempsey, Timothy M, Limper, Andrew H

    “…Dempsey and Limper discuss the study by Swaminathan and colleagues on the use of synthetic (or external) control arms that could be replicated by future…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Management of Mechanical Ventilation in Decompensated Heart Failure by Kuhn, Brooks T, Bradley, Laura A, Dempsey, Timothy M, Puro, Alana C, Adams, Jason Y

    “…Mechanical ventilation (MV) is a life-saving intervention for respiratory failure, including decompensated congestive heart failure. MV can reduce ventricular…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The “Good Person” Sign by Dempsey, Timothy M

    “…Here, Dempsey says when he started medical school, he received a lot of (mostly unsolicited) advice on various topics, ranging from specialty choice to the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Special Populations: Disaster Care Considerations in Chronically Ill, Pregnant, and Morbidly Obese Patients by Dempsey, Timothy M, Lapinsky, Stephanie C, Melnychuk, Eric, Lapinsky, Stephen E, Reed, Mary Jane, Niven, Alexander S

    Published in Critical care clinics (01-10-2019)
    “…Special populations, which include the morbidly obese and patients with chronic, complex medical conditions that require long-term health care services and…”
    Get full text
    Journal Article
  20. 20